The increased expression of LDLR in CAD patients compared to controls seems to underlie the decrease of LDL-C in the plasma of CAD patients due to the increased clearance of LDL through the hepatic LDL receptor [51]. This evidence concerns the gene LDLR and coronary artery disorder.